New research on cannabis and ketamine‐buprenorphine released at APA annual meeting
Alcoholism & Drug Abuse Weekly May 21, 2026 DOI: 10.1002/adaw.34924 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Cannabis Esketamine Ketamine |
Abstract
New research on the relationship between cannabis and psychosis was released, and a presentation on how low‐dose buprenorphine combined with ketamine reduced suicidality in adults with major depressive disorder was published and presented at the annual meeting of the American Psychiatric Association (APA).